Streetbeat News

Stock Prices

CAPL

CrossAmerica Partners (NYSE:CAPL) reported Q1 2024 GAAP EPS of $(0.48), missing the $(0.01) estimate by 4700%, and a 1100% decrease from last year's $(0.04) per share. Sales were $941.548M, missing the $1.169B estimate by 19.45%, and a 7.33% decrease from last year's $1.016B.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:25 pm

COOK

Traeger (NYSE:COOK) reported Q1 2024 adjusted EPS of $0.04, surpassing the $0.03 estimate, with sales of $144.914M also beating the $143.911M estimate. However, this represents a 5.38% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:25 pm

SAFT

Safety Insurance Group (SAFT) reported Q1 earnings of $0.93 per share, surpassing the $0.50 estimate, marking an 86% beat and a significant turnaround from last year's $(0.87) loss per share. Sales rose 25.48% YoY to $268.23M from $213.76M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:25 pm

MKFG

Markforged Holding (NYSE:MKFG) reported Q1 2024 adjusted EPS of $(0.06), surpassing the $(0.07) estimate, with sales of $20.547M exceeding the $20.450M forecast. This represents a 14.29% improvement in EPS and a 0.48% sales beat year-over-year, despite a 14.71% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:24 pm

PFIE

Profire Energy (NASDAQ:PFIE) reported Q1 2024 earnings of $0.03 per share, meeting analyst estimates but marking a 40% decrease from the previous year. Sales were $13.641M, exceeding estimates by 4.13% but showing a 6.27% decrease year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:24 pm

EXAS

Exact Sciences Corp (NASDAQ:EXAS) reported Q1 earnings with a 6% increase in revenue to $638 million, surpassing estimates but posted a larger-than-expected loss of 60 cents per share. The company's screening and precision oncology revenues also saw year-over-year growth. Despite beating revenue forecasts, the larger loss led to a 16% drop in the stock price after hours. Exact Sciences anticipates full-year 2024 revenue between $2.81 billion and $2.85 billion.

Portfolio Pulse from Adam Eckert

May 08, 2024 | 9:23 pm

ASLE

AerSale (NASDAQ:ASLE) reported Q1 2024 adjusted EPS of $0.11, surpassing the $0.04 estimate, with sales of $90.540M exceeding the $85.424M forecast. This represents a 15.68% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:23 pm

VSEC

VSE Corporation (NASDAQ:VSEC) reported Q1 2024 earnings of $0.87 per share, surpassing the consensus estimate of $0.72 by 20.83%. Sales reached $241.539M, exceeding estimates of $237.207M by 1.83%. These figures represent a 22.54% increase in earnings and a 28.08% increase in sales over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:23 pm

GTBIF

Green Thumb Industries (OTCQX:GTBIF) reported an 11% increase in Q1 2024 revenue to $276 million, with a GAAP net income of $31 million, marking a 240% year-over-year increase. Adjusted EBITDA rose to $91 million, and cash flow from operations increased by 12% to $84 million. The growth is attributed to expanded retail operations and consumer packaged goods sales, including 15 additional RISE Dispensaries and new adult-use sales in Maryland. The company also repurchased 1,067,000 shares for $13.6 million.

Portfolio Pulse from Maureen Meehan

May 08, 2024 | 9:22 pm

SUPN

Supernus Pharmaceuticals (NASDAQ:SUPN) reported Q1 sales of $143.600M, missing the consensus estimate of $145.832M by 1.53% and marking a 6.61% decrease from the previous year's sales of $153.764M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 9:21 pm